Cortex Applies for Listing on Nasdaq
- Share via
Dow Jones
Cortex Pharmaceuticals Inc., which has its stock trading over the counter, said Friday it has applied for listing on the Nasdaq market system. The Irvine neuroscience company said in a press release that it has been informed by Nasdaq that the review process may take six to eight weeks.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
